chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received Flucelvax flu vaccine on 10/1/21 at our off-site clinic for Casinos. She had hives, headache, sore arm, and a large swollen lymph node under her arm. Prior to receiving the vaccine she stated that she is allergic to eggs and she also wrote the same on her consent form. I received an email from the HR representative for the clinic relaying the information about her adverse reaction as they believed that we failed to give her an egg-free vaccine. I called the patient and she states that she has been taking Benadryl nonstop over the last few days and most symptoms have subsided with the exception of her sore arm. I did let her know that the Flucelvax she received this year as well as last year is egg-free and preservative free, but that she should follow up with her physician as well and take ibuprofen and use an ice pack for her sore arm and continue taking Benadryl as needed. She had to miss work due to her allergic reaction.
Tremors; Can hardly stand up; Blurred vision; Itching everywhere; Burning of the skin; Light headedness, dizziness; Weakness; Hives; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TREMOR (Tremors), DYSSTASIA (Can hardly stand up), VISION BLURRED (Blurred vision), PRURITUS (Itching everywhere) and SKIN BURNING SENSATION (Burning of the skin) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history was reported.) Concomitant products included PREDNISONE for an unknown indication.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced TREMOR (Tremors), DYSSTASIA (Can hardly stand up), VISION BLURRED (Blurred vision), PRURITUS (Itching everywhere), SKIN BURNING SENSATION (Burning of the skin), DIZZINESS (Light headedness, dizziness), ASTHENIA (Weakness) and URTICARIA (Hives). At the time of the report, TREMOR (Tremors), DYSSTASIA (Can hardly stand up), VISION BLURRED (Blurred vision), PRURITUS (Itching everywhere), SKIN BURNING SENSATION (Burning of the skin), DIZZINESS (Light headedness, dizziness), ASTHENIA (Weakness) and URTICARIA (Hives) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sore throat/enlarged right submandibular node 4/24 - resolved 1-2 days Macular/Papular/Vesicular rash started 4/26 on torso - isolated to abdomen and back - possible widespread shingles Fever, chills started 4/28 and resolved 4/29
heart palpitation, this was not relieved over a week, it feels like drink too much caffeine and very uncomfortable. Small pain in the chest intermittently.  tired, head/muscle pain, little fever
Patient called the pharmacy this morning to report that he was having some swelling in his left arm pit.
There was not an adverse reaction.  The patient was 17 years old when they received their first Moderna vaccine.
Pfizer booster rec'd.  Dizziness, myalgias (all over), fever (highest 101.4), continued until Saturday 10/9/21, diarrhea, nausea. for two days 10/12 and 10/13/21.
got sick after the 1st dose; This spontaneous case was reported by a patient family member or friend and describes the occurrence of ILLNESS (got sick after the 1st dose) in a 76-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (got sick after the 1st dose). At the time of the report, ILLNESS (got sick after the 1st dose) had not resolved.        mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged.       No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2022-653555 (Patient Link).
The afternoon of 8/24, patient was extremely irritable and struggling to verbally communicate, which is very abnormal for him. He laid down for what I thought was a short nap. However, after multiple attempts to wake him, I couldn't. During each of these attempts, patient was delirious and disoriented, and responded incoherently when I tried to converse with him. I was unable to successfully wake him up, and he slept for 13 consecutive hours, with labored breathing throughout the night.
tiredness and weakness in his legs and arms; tiredness and weakness in his legs and arms; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 91-years-old male patient received the first dose of bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Batch/Lot Number: Not reported), via an unspecified route of administration on 09Apr2021 (at the age of 91-years-old) as a single dose for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. On an unspecified date (about 3-4 days after the vaccine) patient experienced tiredness and weakness in his legs and arms (that continues). Reporter wanted to know that for how long the symptoms might last and if her husband should receive the second Pfizer Covid 19 Vaccine. Reporter also wanted to know if Lipitor, Lisinopril, Metoprolol, Nexium and Aspirin might interfere with Pfizer Covid 19 Vaccine. The outcome of events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I gave Flublok 18 yrs & older to a 17 y/o Female. No Adverse outcomes noted. Pt's guardian Notified.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose:01/08/21pfizer,Lot#EL3248 2nd dose: 01/29/21Pfizer,Lot# EN5318 Diagnosed covid positive:04/12/21 Exposure:Travel Symptoms:Sore throat
When I received the booster shot, I became sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (When I received the booster shot, I became sick) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (When I received the booster shot, I became sick). At the time of the report, ILLNESS (When I received the booster shot, I became sick) outcome was unknown.            No concomitant medications was reported. It was reported that the patient had recieved first two doses and two booster shots of Moderna vaccine.   No treatment was reported.   This case was linked to MOD-2022-572014 (Patient Link).
This spontaneous report as received from a pharmacist refers to a unspecified number of patients of unknown age and gender. Patient's medical history, concurrent conditions and concomitant therapies were not provided. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ (lot# M012495 with exp. 09-OCT-2017; lot # M025563 exp. 06-NOV-2017), orally, (dose was not provided). "Since the first excursion occurred of 14 degrees C for 2 hours on an unspecified date" on multiple unspecified dates. The pharmacist reported no adverse effects. There was a data logger issue involved. Temperature: 0 degrees C to 1 degrees C. Time frame: 10 hours. This is one of several reports received from the same reporter. Additional information has been requested.
got lesion in her BRAIN... IT KILLED HER...; This case was reported by a consumer via interactive digital media and described the occurrence of brain lesion in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included oral lesion (had lesion on lip).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced brain lesion (serious criteria death). On an unknown date, the outcome of the brain lesion was fatal. The reported cause of death was brain lesion.   It was unknown if the reporter considered the brain lesion to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient's relative.(son or daughter). The age at vaccination was not reported. The reporter stated that, the patient had lesion on lip, after getting vaccine, the patient had lesion on her brain and it killed her.; Reported Cause(s) of Death: brain lesion
Felt like he had the flu; Achy; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like he had the flu), PAIN (Achy) and FATIGUE (Tired) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Felt like he had the flu), PAIN (Achy) and FATIGUE (Tired). At the time of the report, INFLUENZA LIKE ILLNESS (Felt like he had the flu), PAIN (Achy) and FATIGUE (Tired) outcome was unknown.            It was reported that the patient had no adverse events after the first dose.  No concomitant medications were reported.  No treatment information were reported.
Severe hives and itchy skin, skin feels hot. Got fever at 100F and weakness about 15 days after shot  (tested negative for Covid)  Started in the middle of the nights.  Started on 12/20/2021.  Helped by antihistamine (Allegra, Claritin). Needed to take several times dosage for a week.  25 days later, skin is still sensitive. Rubbing skin makes it red and itchy. Hot showers also make it red, hot and itchy.
Mild vasovagal reaction; Itching; Rash at injection site; This is a spontaneous report from a contactable pharmacist. A 21-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient had a mild vasovagal reaction and rash at injection site. She stayed an hour for observation and said she felt fine but by the time she left, had complained of itching all over. The outcome of the event itching all over was unknown while recovered on unspecified dates for the other events.  Information about lot/batch number has been requested.
102 degree fever, lasting 4 hours Dizziness, lasting 6 hours Muscle aches, lasting 14 hours  Headache, lasting 6 hours Fatigue, 14 hours
This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 31-JUL-2018, the patient was vaccinated with an improperly stored dose of VARIVAX lot # N031939, expiration date 13-NOV-2019 (exact dose and route of administration were not reported). The vaccine was reconstituted with properly stored sterile diluent (lot# N030173, expiration date 02-JUL-2020). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion between -9 to 8 degrees Celsius for 9 hours and 45 minutes. Data logger was involved. There were no previous excursions reported. No product quality complaint (PQC) was involved.
Information has been received from a nurse practitioner concerning an approximately 22 year old female patient who on 27-MAR-2008 was vaccinated with a second dose of 0.5 ml of GARDASIL (LOT# 659182/1757U), intramuscularly. The patient was diagnosed with low grade human papilloma virus (HPV). Papanicolaou tests were performed in 2008, which were positive for low grade HPV. The patient sought medical attention at a clinic. At the time of the report, the outcome of the patient was unknown. This is one of several reports from the same source. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
Hx Covid infection in June. Couldn't Lift ARM, 100.3 degree F temp NOW with chest & arm RASH Txt Antihistamine & steroid pak
Event: Rash with hives over most of body ER Treatment: IV steroid and antihistamine pill; Home: 5 days of prednisone and antihistamine pills
Patient developed a blotchy rash later in the evening (exact time unknown) after receiving first dose of vaccine at about 2 pm at pharmacy.  Patient's husband took her to the emergency room.  Patient received prescription for prednisone 20mg and Benadryl 25mg (bought Benadryl otc as was not covered by insurance).
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 04-Oct-2020 and the estimated date of delivery was 10-Jul-2021. On 17-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-third week of the pregnancy.  On 17-Mar-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown.            No concomitant medications were provided.  Treatment medications were unknown.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021 at 10:03 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 9:49 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 60.51 for dose administered on 27-Feb-2021 and 60.59 for dose administered on 27-Mar-2021.  Concomitant product use was not provided by the reporter.  Batch number 014M20A underwent temperature excursion on 27-Feb-2021 with temperature 33, 34 and 35 degrees Fahrenheit from 09:00 AM to 05:00 PM. This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 27-Feb-2021.  Batch number 019B21A underwent temperature excursion on 27-Mar-2021 with temperature 35 degrees Fahrenheit from 09:00 AM to 10:00 AM. This vial was moved to fridge on 23-Mar-2021 and beyond use date for the vial was reported as 22-Apr-2021. Product moved to clinic on 27-Mar-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  Treatment information was not provided.   This case was linked to MOD-2022-566976 (Patient Link).
Patient is 57 years old female with history of diabetes and hypertension who developed upper respiratory tract infection about 2 weeks ago and after that she started having generalized weakness in all extremities but after few days she got better.  For the last 3 days her progression of her weakness get worse where she cannot walk anymore so she presented to the emergency room with upper and lower extremities generalized weakness.  She was found also to have UTI.  She denied dysuria.  No nausea no vomiting.  No headache.  MRI of the brain and C-spine was not conclusive to explain her weakness.   57 Years old  Female with a history of diabetes and hypertension presenting with a feeling of generalized weakness, which began 3 days ago.  Patient states that she feels generalized weakness in the lower extremity's the upper extremities. Patient states that she has more weakness on her left lower extremity compared to her right lower extremity.  Patient needs assistance in order to stay ambulate. Symptoms have progressively gotten worse with tingling radiation. The weakness has been constant. The patient is feeling unsteady and off-balance when attempting to walk. Patient also feels pain her back which begun approximately the same time as her weakness condition.
Child vaccinated at a drive thru clinic. On paperwork at clinic, mother documented date of birth as 02/23/2009. Upon entering in data into electronic system, noted that child date of birth is listed as 02/23/2010. Contacted parent to verify birth date. Initially mother stated date of birth was the 2/23/2009 that she listed on the consent form, but then stated "actually, it is 02/23/2010".  This nurse then asked parent if she lied about the birthdate so that child could get vaccinated and she stated "yes". Advised parent that vaccine is not licensed for children under 12 years of age and that we would not vaccinate with second dose until that time.
p/getting flu vax started feeling like had no energy;had same rxn last yr but did not occur until 1wk p/shot & lasted 3 wks;still feeling blah
Mild joint pain/fatigue the day after vaccine. One week after, major headache and rash at vaccine spot.
Developed left shoulder area pain approx. 3-4 days after influenza vaccine. Pain reported to be moderate to severe and burning in nature. Occasional radiating pain down left arm to left 3rd finger and paresthesias. Plan to follow 12/4/18. When seen on 11/27/18, patient did not have fever, temp was 97.6. Muscle strength intact 5/5 with shoulder abduction, elbow flexion, elbow extension wrist extending hand grasp and finger abduction. Sensation intact left arm, hand and fingers to light touch. DTR Left triceps trace, biceps and brachioradialis lt and symmetric to right upper extremity. Shoulder ROM and strength full and symmetric. No palpable trapezius or paracervical muscle tenderness. No neck or supraclavicular lymphadenopathy. No rashes on shoulder, breast, axilla or trunk to suggest shingles. No redness or swelling at injection site left deltoid. Mild tenderness with deep palpation over left deltoid injection site. No signs of infection at left deltoid injection site. Plan to follow and re-examine patient on 12/4/2018 to check for development of muscle weakness. In the meantime, patient advised to take ALEVE, apply cool compress, perform gentle shoulder ROM and avoid strenuous lifting or activity using left upper extremity. Presentation is most consistent with left brachial neuritis.
Received vaccine Friday afternoon. By Saturday morning, one large "blister" appeared on my left forearm, By Saturday evening, 3 more smaller blisters appeared on my left hand. They are itchy and painful. I also had some itching at the vaccine site but it abated quickly.
Patient was administered second moderna covid vaccine on 3/11/21 and date due was 3/16/21
Tightness & swelling in throat about 20 mins p/1st inject; resolved spontaneously p/15-20mins; 8JUN93 pt was sent to allergist;
Irritation on upper thigh which then turned into shingles; Irritation on upper thigh which then turned into shingles; This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (Irritation on upper thigh which then turned into shingles) and HERPES ZOSTER (Irritation on upper thigh which then turned into shingles) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 048A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included EZETIMIBE, ROSUVASTATIN, FENOFIBRATE, IBANDRONATE SODIUM (BONIVA), PANTOPRAZOLE and ATENOLOL for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Jun-2021, the patient experienced SKIN IRRITATION (Irritation on upper thigh which then turned into shingles) and HERPES ZOSTER (Irritation on upper thigh which then turned into shingles). The patient was treated with GABAPENTIN at a dose of UNK, prn. At the time of the report, SKIN IRRITATION (Irritation on upper thigh which then turned into shingles) and HERPES ZOSTER (Irritation on upper thigh which then turned into shingles) outcome was unknown.